Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Unapproved Peptides Common in Australia Despite Crackdown

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

FPT Plus Pulsed Dye Laser Effective for Port-Wine Birthmarks

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Skin Cancer: 5 Practical Tips for Earlier Detection

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

Dermatology AI Is Here. Now Comes the Hard Part

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Tumor Biomarker Improves Surveillance of MCC Recurrences

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Candida auris Infections Persist, CDC Report Shows

Clinical and screening cases of C auris doubled between 2022 and 2024.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Latest News

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Clinical and screening cases of C auris doubled between 2022 and 2024.

News All Time

Personalizing Chronic Spontaneous Urticaria Care in Community-Based Allergy/Immunology Practices: Examining Pathogenesis, Endotypes, and Therapeutic Options

Personalizing Chronic Spontaneous Urticaria Care in Community-Based Allergy/Immunology Practices: Examining Pathogenesis, Endotypes, and Therapeutic Options

New Name for PCOS More Accurately Reflects Condition

The condition is now called polyendocrine metabolic ovarian syndrome

Make the Diagnosis: This Is a Curious Cluster. Can You Diagnose It?

A 21-year-old woman visited her doctor for multiple moles on her chest that first developed in her early teenage years and progressively increased in size and quantity over the years. Can you diagnose the patient?

GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis

Adding tirzepatide helped patients shed pounds, improved complete skin clearance rates

Pediatric Hereditary Angioedema Treatment Options Growing

From scant data, the armamentarium is expanding, with an increasing evidence base

The Truth About 'Life-Changing Sunburns,' According to a Dermatologist

Can one severe sunburn have serious consequences?

Volixibat Soothed the Itch in Primary Sclerosing Cholangitis

IBATS inhibitor led to improvement in cholestatic pruritus

PCSK9 Inhibitors Linked to Better Survival in Some Cancer Patients on Immunotherapy

Prospective clinical trials needed to validate the findings

Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

Adjuvant approach will need confirmation from ongoing phase III trial, says expert

Trump's Hair-Loss Drug; Bringing Americans With Ebola to U.S.; Widespread ACA Fraud?

Health news and commentary gathered by MedPage Today staff

Novel Lupus Drugs Continue to Shine in Extended Early Data

For one of the two, the benefits continue long after treatment stops

How Much Prednisone Is Too Much in Treating Rheum Effects From Cancer Therapies?

French study posits an answer

What Is Causing This Woman's Swollen Chin?

A long and challenging diagnostic path with twists and turns

FDA OKs First New Sunscreen Ingredient in a Quarter Century

Bemotrizinol blocks UVA and UVB and has been available in Europe since 1999

New Type of Maggots Cleared by FDA as Medical Treatment

Non-antibiotic approach can help deal with non-healing necrotic skin and soft tissue wounds

Is Microdosing Accutane Safe? Dermatologist Weighs In

Patients take the medication less frequently to reduce side effects while gleaning benefits

Recommended News For You

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

PSMA PET Beats MRI in Prostate Cancer Staging Study

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

Novel radiotracer identifies biomarker for triple-negative breast cancer

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

Recommended Articles For You

An Overview Of Daunorubicin: What Is It Used For And How Does It Work? 

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity 

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes 

Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Should the UK introduce targeted prostate cancer screening? The case for and against

2.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

3.

Radiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipment

4.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

5.

Older Adults With Advanced Cancer Prioritize Quality of Life

1.

How AI is Transforming Diagnostics, Drug Discovery, and Personalized Oncology

2.

Cloud-Based Hematology Care Pathways: Integrating Digital Transformation in Blood Disorders Management

3.

The Capmist DM: A Revolutionary Way to Combat Dry Mouth

4.

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC

5.

The Unseen Threat: Uncovering the Risks of Pancoast Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

5.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot